pharmacie et médicaments – Mise à disposition des patients des médicaments de thérapies innovantes

This written question concerns the availability of innovative medicines for patients in France. It seeks to understand the current situation and potential challenges in accessing these advanced therapies. The question addresses patients, healthcare providers, and pharmaceutical companies. It aims to ensure timely and equitable access to cutting-edge treatments.